S23 SARM Capsules

Product Details S-23 is a synthetic compound classified within the category of selective androgen receptor modulators (SARMs). It was developed through structural modification of earlier investigational compounds to enhance receptor interaction characteristics at the molecular level. In controlled research environments, S-23 is examined for its binding properties and interaction with androgen receptors. Its chemical structure supports consistent investigation into receptor-ligand dynamics, making it suitable for studies focused on molecular signaling and receptor selectivity. This compound is supplied strictly for laboratory research purposes and is not intended for consumption, medical, or diagnostic use. Mechanism of Action At the molecular level, S-23 is studied for its selective binding affinity to androgen receptors. Upon interaction, it forms a receptor-ligand complex that may influence receptor conformation and subsequent intracellular signaling pathways. This interaction is analyzed in vitro to evaluate receptor selectivity, binding strength, and downstream transcriptional activity. Researchers examine how S-23 modulates androgen receptor-mediated gene expression and signaling cascades under controlled experimental conditions. Additionally, studies focus on how structural modifications within the compound contribute to receptor specificity and interaction dynamics, supporting broader investigation into selective receptor modulation mechanisms. Chemical Properties of S-23 Attribute Details Compound Name S-23 Classification Selective androgen receptor modulator (SARM) Molecular Formula C18H13ClF4N2O3 Molecular Weight 416.76 g/mol CAS Number 1010396-29-8 IUPAC Name (2S)-N-(4-cyano-3-trifluoromethylphenyl)-3-(3-fluoro-4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide Primary Target Androgen receptor Research Context Receptor binding and transcriptional signaling analysis Format Research compound (non-consumable) Stability Stable under controlled laboratory storage conditions Research Applications Receptor Binding Studies S-23 is utilized in experimental models to examine ligand interaction with androgen receptors. Researchers analyze binding affinity and receptor selectivity at the molecular level. Gene Expression and Signaling Analysis This compound is applied in studies focused on androgen receptor-mediated transcriptional activity. Investigations explore how receptor engagement influences intracellular signaling pathways and gene regulation. Structure-Activity Relationship Research S-23 supports research into how structural variations affect receptor interaction and selectivity. These studies contribute to a broader understanding of ligand design and receptor modulation. Why Choose BehemothLabz to Buy S-23 for Research BehemothLabz provides research-grade S-23 manufactured under controlled laboratory conditions with strict quality assurance protocols. Each batch undergoes analytical verification to ensure consistency in molecular composition and purity. Comprehensive documentation, including laboratory testing reports and sourcing transparency, supports reproducibility in experimental settings. BehemothLabz maintains a compliance-focused approach, supplying compounds intended strictly for laboratory-based investigation and analytical research Disclaimer S-23 is intended strictly for laboratory research and analytical purposes only. It is not intended for use in diagnostic procedures, therapeutic applications, or in vivo studies of any kind. Any references to biochemical pathways, receptor interactions, or enzymatic processes are provided solely for informational and research-context purposes. This compound must be handled exclusively by qualified professionals in controlled laboratory environments in accordance with applicable regulations and safety guidelines. Improper handling or use outside of controlled research settings is strictly prohibited. References Ameline, A., Gheddar, L., Raul, J. S., & Kintz, P. (2022). In vitro characterization of S-23 metabolites produced by human liver microsomes, and subsequent application to urine after a controlled oral administration. Journal of pharmaceutical and biomedical analysis, 212, 114660. https://doi.org/10.1016/j.jpba.2022.114660 So, Y. M., Wong, J. K. Y., Choi, T. L. S., Prabhu, A., Stewart, B., Farrington, A. F., Robinson, P., Wan, T. S. M., & Ho, E. N. M. (2021). Metabolic studies of selective androgen receptor modulators RAD140 and S-23 in horses. Drug testing and analysis, 13(2), 318–337. https://doi.org/10.1002/dta.2920